MetLife Inc.'s (NYSE:MET) performance has been detailed through several reports. Shares of MetLife were sold by the Massachusetts Financial Services Co. MA while the financial services organization has also declared Q2 2024 dividends on its preferred stock. Financial advisories such as Wells Fargo & Company have led to price-target reductions down to $85.00. Despite price cuts, MetLife still offers an attractive insurance play according to reports. MET's Q1 earnings have successfully met estimates and reflect a year on year increase, attributed to reduced expenses. However, experts maintained a cautious approach, recommending thoughtful play ahead of the Q1 earnings announcement. There's an anticipation of earnings decline as per several analyst estimations. Contrarily, Mitsubishi UFJ Asset Management Co. Ltd raised its position in MetLife. MetLife's Q1 2024 earnings call transcript is available, offering an insight into the company's financial performance. MetLife's dividends have reportedly increased, rendering the stock more attractive. In other developments, the company has launched a pet health and wellness app with Microsoft, showing its inclination towards innovative solutions. Nonetheless, there's a bearish view as MetLife's Q4 earnings miss estimates due to high costs and a weak EMEA unit.
Metlife MET News Analytics from Thu, 03 Aug 2023 07:00:00 GMT to Thu, 16 May 2024 16:17:44 GMT -
Rating 0
- Innovation 2
- Information 6
- Rumor -4
